Acadian Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $289K | Hold |
|
|||||
|
2025
Q1 | $300K | Buy |
|
|||||
|
2024
Q4 | $80K | Buy |
|
|||||
|
2024
Q3 | $42K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $347K | Sell |
|
|||||
|
2020
Q4 | $4.49M | Sell |
|
|||||
|
2020
Q3 | $8.7M | Sell |
|
|||||
|
2020
Q2 | $15.9M | Buy |
|
|||||
|
2020
Q1 | $7.57M | Buy |
|
|||||
|
2019
Q4 | $9.94M | Sell |
|
|||||
|
2019
Q3 | $14.5M | Sell |
|
|||||
|
2019
Q2 | $19.5M | Sell |
|
|||||
|
2019
Q1 | $25.7M | Buy |
|
|||||
|
2018
Q4 | $24.1M | Sell |
|
|||||
|
2018
Q3 | $44M | Sell |
|
|||||
|
2018
Q2 | $67.2M | Sell |
|
|||||
|
2018
Q1 | $52.2M | Sell |
|
|||||
|
2017
Q4 | $51M | Buy |
|
|||||
|
2017
Q3 | $50.2M | Sell |
|
|||||
|
2017
Q2 | $67.1M | Sell |
|
|||||
|
2017
Q1 | $50.7M | Sell |
|
|||||
|
2016
Q4 | $42M | Sell |
|
|||||
|
2016
Q3 | $43M | Buy |
|
|||||
|
2016
Q2 | $31.1M | Buy |
|
|||||
|
2016
Q1 | $22.3M | Sell |
|
|||||
|
2015
Q4 | $21.9M | Buy |
|
|||||
|
2015
Q3 | $10.1M | Buy |
|
|||||
|
2015
Q2 | $10.2M | Buy |
|